| Ticker Details |
Illumina, Inc.
Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.
|
| IPO Date: |
July 28, 2000 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$33.13B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.43 | 1.92%
|
| Avg Daily Range (30 D): |
$4.28 | 2.20%
|
| Avg Daily Range (90 D): |
$3.84 | 2.31%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.25M |
| Avg Daily Volume (30 D): |
1.56M |
| Avg Daily Volume (90 D): |
1.53M |
| Trade Size |
| Avg Trade Size (Sh.): |
83 |
| Avg Trade Size (Sh.) (30 D): |
47 |
| Avg Trade Size (Sh.) (90 D): |
48 |
| Institutional Trades |
| Total Institutional Trades: |
25,611 |
| Avg Institutional Trade: |
$7.08M |
| Avg Institutional Trade (30 D): |
$12.27M |
| Avg Institutional Trade (90 D): |
$11.05M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
5 |
| Market Closing Trades |
| Avg Closing Trade: |
$21.17M |
| Avg Closing Trade (30 D): |
$45.16M |
| Avg Closing Trade (90 D): |
$45.31M |
| Avg Closing Volume: |
120.9K |
|
|
| Financials |
| |
TTM |
Q2 2027 |
Q4 2026 |
|
Basic EPS
|
$5.4
|
$1.37
|
$.88
|
|
Diluted EPS
|
$5.36
|
$1.35
|
$.87
|
|
Revenue
|
$4.49B
|
$1.16B
|
$1.09B
|
|
Gross Profit
|
$2.98B
|
$770M
|
$721M
|
|
Net Income / Loss
|
$824M
|
$207M
|
$134M
|
|
Operating Income / Loss
|
$882M
|
$245M
|
$209M
|
|
Cost of Revenue
|
$1.51B
|
$389M
|
$370M
|
|
Net Cash Flow
|
$106M
|
|
$-329M
|
|
PE Ratio
|
|
|
|
|
|
|
